demat accounts today (Friday, June 7). The refunding process for individuals who have not yet received their shares will also be completed today.The speciality chemical company's subscription period began on Monday, June 3, and ended on Wednesday, June 5.
By the end of the final bidding day, the issue had received a significant response from all three segments: non-institutional investors (NIIs) (301.92 times), qualified institutional buyers (QIBs) (89.03 times), and retail investors (54.23 times). On the third day, Kronox Lab Sciences IPO subscription status was 117.25 times.Also Read: Kronox Lab Sciences IPO day 3: GMP, review to subscription status.
Apply or not?Half of the issue size was set aside for qualifiedinstitutional buyers, 35% for retail investors, and the remaining 15% for non-institutional investors. Furthermore, investors couldbid for a minimum of 110 stock shares, followed by multiples of 110 equity shares.Kronox Lab Sciences Limited was founded in 2008 and manufactures specialised fine chemicals of high purity for a variety of end industries.
APIs, pharmaceutical formulations, scientific research, nutraceuticals, agrochemical formulations, metal refineries, personal care products, and animal health products are all manufactured by the company. These are only a few applications for its high purity speciality fine chemicals.Also Read: Kronox Lab Sciences IPO allotment finalised today; latest GMP, step-by-step guide to check statusLet's check what does Kronox Lab Sciences IPO GMP today signal ahead of listing.Kronox Lab IPO GMP today or grey market premium is +33.
Read more on livemint.com